Eden Biologics

Eden Biologics is a Taiwan-based startup in the biopharmaceutical industry, focusing on developing and manufacturing high-quality biologics at an affordable cost. Established in 2012, the company's vision is to make world-class biopharmaceuticals accessible to all patients globally through innovation, dedication, and efficiency. The company's mission is to provide world-class process development and manufacturing services in Asia to companies developing and commercializing high-quality affordable biologic medicines for regional and global distribution. Eden Biologics aims to achieve this by utilizing manufacturing innovations and leveraging the expertise of their highly experienced team of biopharmaceutical industry veterans. In October 2018, the company received a Post-IPO Equity investment from Sanofi, a significant milestone that reflects investor confidence in the company's potential. With a focus on industries such as biopharma, biotechnology, healthcare, and pharmaceuticals, Eden Biologics is poised to make a significant impact on the biopharmaceutical landscape, driven by its dedication to affordability and accessibility in the global market.